King Signs Generic Altace Distribution Agreement With Cobalt
This article was originally published in The Pink Sheet Daily
Executive Summary
Patent infringement litigation between the two companies is ongoing.
You may also be interested in...
King Needs Second Trial In Order To Get Pediatric Extension for Altace
The company has until October 2008 to complete another study after initial FDA rejection.
King Needs Second Trial In Order To Get Pediatric Extension for Altace
The company has until October 2008 to complete another study after initial FDA rejection.
Merck Moves To Refuel Hypertensive Portfolio
The company gains exclusive rights to NicOx’ nitric oxide-donating technology for use with systemic hypertension treatments.